Gyala Therapeutics | Finanzwire

Basculer en Français

9838	Companies
197491	Keywords
128575	Articles
105034	Press releases

Home
Companies
Gyala Therapeutics

BRIEF

published on 02/10/2026 at 12:10, 3 hours 47 minutes ago

Gyala Therapeutics Launches Phase I/IIa Trial for CAR-T Therapy in Acute Leukemias

Clinical Trial CAR-T Cell Therapy Gyala Therapeutics Acute Leukemias CD84 Protein
PRESS RELEASE

published on 02/10/2026 at 12:05, 3 hours 52 minutes ago

Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute leukemias with limited treatment options
Gyala Therapeutics starts Phase I/IIa trial of CAR-T cell therapy for acute leukemias, targeting CD84 protein. Study evaluates safety and efficacy in AML and T-ALL patients with limited options

Phase I/IIa Trial CAR-T Cell Therapy Gyala Therapeutics Acute Leukemias CD84 Protein

Accesswire

Published on 02/10/2026 at 15:30, 27 minutes ago

Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 57 minutes ago

Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 15:00, 57 minutes ago

Vox Royalty Releases Annual Investor Letter
Published on 02/10/2026 at 14:30, 1 hour 27 minutes ago

Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 1 hour 57 minutes ago

Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7

View all ACCESSWIRE

EQS Group

Published on 02/10/2026 at 15:30, 27 minutes ago

Nebius announces agreement to acquire Tavily to add agentic search to its AI cloud platform
Published on 02/10/2026 at 15:15, 42 minutes ago

Kasowitz and Mishcon de Reya Comment on Tirana Mayor Erion Veliaj's Year in Detention: For 365 Days and Counting, Mayor Veliaj Suffers Denials of Due Process Rights and Apparent Political Persecution
Published on 02/10/2026 at 15:09, 47 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 02/10/2026 at 15:09, 48 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 02/10/2026 at 15:08, 49 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 02/09/2026 at 17:45, 22 hours 12 minutes ago

Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:40, 22 hours 17 minutes ago

Disclosure of the number of shares and the total number of voting rights as of January 31, 2026
Published on 02/09/2026 at 17:40, 22 hours 17 minutes ago

260209 BENETEAU FY 2025 Revenue
Published on 02/09/2026 at 17:35, 22 hours 22 minutes ago

Disclosure of transactions in own shares from February 2 to February 6, 2026
Published on 02/09/2026 at 08:30, 1 day 7 hours ago

THERMADOR GROUPE : Plan to separate the roles of chairman and chief executive officer

View all LES ECHOS COMFI WIRE